IMU 2.08% 4.9¢ imugene limited

RAC is a speciall case. chemo is being threatened by both CarT...

  1. 4,385 Posts.
    lightbulb Created with Sketch. 2046
    RAC is a speciall case. chemo is being threatened by both CarT and immunotherapy. Chemo has average response rates and Adverse ebents. CarT has really good response rates and serious events. immunotherapy is proving to have good response rates and good safety.

    One wonders how much longer chemo will be around?

    The IMU share price now, is where the market thinks it should be. Doesnt matter why really. But what the market values it at with more beautiful data might make evryone happy.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.